TELECONFERENCE

High Alert Medication Series Part I
Reducing the Risk of Patient Harm from Opiates

Registration for the teleconference has expired.

PROGRAM OVERVIEW Opiates continue to be among the Top 10 medications/class of medications considered to be high-alert, and are responsible for patient injury in all types of healthcare settings. Errors with opiates lead to serious adverse events, including allergic reactions, failure to control pain, over-sedation, respiratory depression, seizures, and even death. ISMP invites all safety-minded practitioners to join us for the next teleconference entitled Reducing the Risk of Patient Harm from Opiates on January 21, 2009 from 1:30 to 3:00 pm ET. As part I of ISMP’s four-part teleconference series on high-alert medications, this important program is a “must hear” broadcast for healthcare leaders and practitioners interested in making a significant impact on medication safety. Join the ISMP experts as they identify common types of errors that occur with opiates and barriers to optimal therapy, and provide high-leverage strategies that can be immediately implemented to reduce patient harm. The following topics will be discussed: • Patient assessment and prescribing of opiates • Monitoring of therapy • Use of reversal agents • Dosing errors • Mistakes due to similar labeling and packaging • Mistakes due to look- and sound-alike drug names • Lack of standardization of drug concentrations • Drug storage issues • Measures to evaluate the safety of opiate use

INTENDED AUDIENCE (Interdisciplinary teams are encouraged to attend together):

• Physicians
• Nurses
• Pharmacists
• Physician Assistants
• Risk and Quality Managers
• Medication Safety and Patient Safety Officers

OBJECTIVES

Following completion of this teleconference, participants should be able to:

• Describe common preventable adverse events with opiate therapy and their causes
• Identify best practices that can improve safety when prescribing, dispensing, and administering opiates
• Discuss the role of the practitioner in monitoring and managing the care of patients who are receiving opiates
• Construct two measures that can used to assess the safety of opiate therapy

MODERATOR

• Matthew Fricker, RPh, MS, Program Director, Institute for Safe Medication Practices

SPEAKERS

• Matthew Grissinger, RPh, FISMP, FASCP, Director, Error Reporting Programs, Institute for Safe Medication Practices

PRICING INFORMATION

Live Teleconference	$215.00
Live Teleconference and Teleconference CD	$245.00 (Plus $5.00 S&H)
Teleconference CD	$215.00 (Plus $5.00 S&H)
*CD includes a file of the audio recording of the teleconference as well as PowerPoint files containing slides of each presentation.

TELECONFERENCE POLICIES

Registration

• One telephone line connection is allowed per registration. Others may listen on this telephone line via an internal extension, or a speakerphone may be used for larger groups.
• You may not set up conferencing capabilities for other sites outside the facility. Each specific site may be used for larger groups. Each specific site must register individually.
• We cannot accept registrations without an email address and the name of a contact person.
• Registration for this teleconference will end at midnight ET on 1/20/2009.
• CDs will be available for purchase after the teleconference.

Cancellations

• Cancellations must be requested via an email message to our teleconference department.
• Cancellations received before the start (1:30 pm ET) of the teleconference will receive a full refund or credit.
• Cancellations received after the start (1:30 pm ET) of the teleconference and within 3 business days after the teleconference will be assessed a cancellation fee of $50.00.
• If your organization does not cancel within 3 business days after the date of the teleconference and does not participate, the full registration fee will be charged.

Materials

• If your organization's registered participant does not receive the teleconference materials that are sent out approximately 2 days before the teleconference via email, please send an email message to our billing department prior to the start of the teleconference.
  
• When registering, please be sure to provide the email address of the person to whom ISMP should send these materials.

---

Accreditation Information:

NOTE: There is no additional charge for continuing education credits for this teleconference.

Pharmacy Continuing Education Continuing education credits will be provided by The Pediatric Pharmacy Advocacy Group. PPAG is an approved provider of continuing pharmacy education by the Accreditation Council for Pharmacy Education (ACPE). This program has been approved for 1.5 contact hours (0.15 CEUs). The UPN is: 180-999-09-524-L04-P. Nursing Continuing Education Debora Simmons is approved by the California Board of Nurse Examiners as a provider of continuing nursing education. This program has been assigned the Universal Program Number CEP 13677 and is approved for 1 contact hours (0.1 CEUs) of continuing nursing education.